American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$229M |
| 2 |
Johnson & Johnson
JNJ
|
+$202M |
| 3 |
JPMorgan Chase
JPM
|
+$193M |
| 4 |
Citizens Financial Group
CFG
|
+$174M |
| 5 |
Automatic Data Processing
ADP
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$199M |
| 3 |
PNC Financial Services
PNC
|
+$196M |
| 4 |
NXP Semiconductors
NXPI
|
+$155M |
| 5 |
Cisco
CSCO
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.53% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 11.86% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Allison Transmission
ALSN
$10.2B
| $872K | ﹤0.01% |
+25,875
| New | +$805K |
|
1152
Simpson Manufacturing
SSD
$7.99B
| $867K | ﹤0.01% |
19,823
-3,319
| -14% | -$149K |
|
1153
Pentair
PNR
$10.5B
| $864K | ﹤0.01% |
22,944
-363
| -2% | -$14.2K |
|
|
TSS
1154
DELISTED
Total System Services, Inc.
TSS
| $858K | ﹤0.01% |
17,508
-277
| -2% | -$13.6K |
|
1155
Sinclair Inc
SBGI
$1B
| $852K | ﹤0.01% |
25,534
-2,259
| -8% | -$67.3K |
|
1156
Banco Santander Chile
BSAC
$16B
| $850K | ﹤0.01% |
38,860
-6,170
| -14% | -$135K |
|
1157
Philips
PHG
$26.2B
| $848K | ﹤0.01% |
37,482
-100,837
| -73% | -$2.2M |
|
|
CHUY
1158
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $845K | ﹤0.01% |
26,035
-26,822
| -51% | -$812K |
|
1159
Federated Hermes
FHI
$4.7B
| $842K | ﹤0.01% |
29,773
-6,142
| -17% | -$170K |
|
|
KMG
1160
DELISTED
KMG Chemicals Inc
KMG
| $830K | ﹤0.01% |
21,330
+424
| +2% | +$13.5K |
|
1161
TransDigm Group
TDG
$68.3B
| $826K | ﹤0.01% |
3,317
+47
| +1% | +$12.3K |
|
1162
Knowles
KN
$3.33B
| $811K | ﹤0.01% |
+48,514
| New | +$757K |
|
|
XLRN
1163
DELISTED
Acceleron Pharma
XLRN
| $811K | ﹤0.01% |
31,768
-1,163
| -4% | -$36.8K |
|
1164
Amdocs
DOX
$6.08B
| $806K | ﹤0.01% |
13,841
-830
| -6% | -$49K |
|
|
NBLX
1165
DELISTED
Noble Midstream Partners LP
NBLX
| $797K | ﹤0.01% |
22,139
-130,045
| -85% | -$4.17M |
|
|
NXTM
1166
DELISTED
NxStage Medical Inc.
NXTM
| $791K | ﹤0.01% |
30,173
-34,754
| -54% | -$860K |
|
|
KATE
1167
DELISTED
Kate Spade & Company
KATE
| $791K | ﹤0.01% |
+42,343
| New | +$694K |
|
1168
KeyCorp
KEY
$24.5B
| $788K | ﹤0.01% |
43,141
-2,003,349
| -98% | -$31.6M |
|
1169
John B. Sanfilippo & Son
JBSS
$989M
| $786K | ﹤0.01% |
+11,161
| New | +$686K |
|
1170
TherapeuticsMD
TXMD
$24.1M
| $786K | ﹤0.01% |
2,726
-790
| -22% | -$245K |
|
1171
Targa Resources
TRGP
$57.6B
| $785K | ﹤0.01% |
+14,008
| New | +$708K |
|
1172
Align Technology
ALGN
$12.4B
| $781K | ﹤0.01% |
+8,124
| New | +$754K |
|
1173
SunCoke Energy
SXC
$801M
| $781K | ﹤0.01% |
+68,900
| New | +$732K |
|
1174
STMicroelectronics
STM
$48.4B
| $778K | ﹤0.01% |
68,537
-46,746
| -41% | -$443K |
|
|
ESV
1175
DELISTED
Ensco Rowan plc
ESV
| $772K | ﹤0.01% |
19,855
-797
| -4% | -$28.6K |
|
Similar funds
American Century Companies's Q4 2016 Portfolio in Review
As of Q4 2016, American Century Companies held 1,486 positions worth $92.8B, up 1.9% from $91B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
American Century Companies's Q4 2016 filing shows 166 new, 494 increased, 617 reduced and 173 closed positions. Its largest new stake was Citizens Financial Group: 5,752,874 shares worth $205M. The largest sale was Pfizer, an estimated $288M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- American Century Companies's largest Q4 2016 buy was Citizens Financial Group: 5,752,874 shares worth $205M.
- American Century Companies added most to Chevron in Q4 2016, an estimated $229M increase.
- American Century Companies's biggest Q4 2016 reduction was Pfizer, cutting an estimated $288M.
- American Century Companies fully exited Liberty Global Class A in Q4 2016, selling an estimated $116M.
- American Century Companies's ten largest holdings make up 13% of its $92.8B portfolio in Q4 2016.
- American Century Companies opened 166 new positions and closed 173 in Q4 2016.
- American Century Companies's portfolio value rose 1.9% quarter-over-quarter to $92.8B.
Based on American Century Companies's 13F filing for Q4 2016, filed 3 Feb 2017.